OGEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Oragenics Inc (OGEN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The stock shows no strong positive catalysts, weak financial performance, and lacks significant trading signals or sentiment to support a buy decision. The technical indicators are neutral, and the stock's trend suggests a potential decline in the short term.
The MACD is positive and expanding, indicating some bullish momentum. However, the RSI is neutral at 73.23, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 0.814, with resistance at 0.958 and support at 0.67. Overall, the technical indicators are inconclusive for a strong buy signal.
NULL identified. There is no recent news, and hedge fund and insider trading activity are neutral.
The stock is down 2.96% in pre-market trading. Financial performance is weak, with negative net income and EPS dropping significantly YoY. The stock trend analysis predicts a decline of -0.16% in the next day, -0.33% in the next week, and -2.99% in the next month.
In Q3 2025, revenue remained at 0 with no growth. Net income improved slightly to -$3,066,589 (up 24.51% YoY), but EPS dropped significantly to -1.96 (-82.69% YoY). Gross margin remains at 0. Overall, the financials indicate poor performance and no growth.
No analyst ratings or price target changes available.
